Drugs approved for "wet" age-related macular degeneration also appeared to be effective in diabetic macular edema in several clinical studies, researchers said here.
Ranibizumab (Lucentis) and pegaptanib (Macugen), both of which inhibit vascular endothelial growth factor (VEGF) signalling, were highly effective in improving visual acuity in patients with this form of diabetic retinopathy in a series of randomized, controlled trials, according to reports at the American Academy of Ophthalmology's annual meeting.
Full Article
No comments:
Post a Comment